Biotech entity
Every one of those 1 sits in a single category, pharma. Caritas is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. The tracked stories average 3 original sources each. Justin Zanamuzi appears in 1 tracked Biotech story from June 28, 2026.
Last mentioned: Jun 28, 2026
Entity pulse
Coverage balance Negative coverage leads. Negative coverage exceeds positive coverage by 100 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
Every one of those 1 sits in a single category, pharma. Caritas is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. The tracked stories average 3 original sources each. Justin Zanamuzi appears in 1 tracked Biotech story from June 28, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 9 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Justin Zanamuzi. Shared-story counts are live from our verified record — not editorial picks.
At least 30 deaths with Ebola symptoms in a crowded DRC camp highlight untreated spread and demand for rapid point-of-care diagnostics and expanded vaccine access. With 5 million displaced at risk, biopharma firms face calls to accelerate countermeasure deployment.
Source: tribune.com.pk · examiner.com.au
Justin Zanamuzi is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
